Interference

Companies Interference

CANDOR Bioscience GmbH, Germany

CANDOR - The ELISA Experts Stabilizers and Optimizers for Immunoassays CANDOR Bioscience GmbH offers buffer and solutions for optimising and stabilising immunoassays. For reliable results. • LowCross-Buffer® - Optimizer developed to minimise interference such as non-specific binding, cross react more

Publications Interference

• Overexpression of Sulf2 in idiopathic pulmonary fibrosis

  Previously, we have shown that heparan sulfate (HS) 6-O-endosulfatase 1 (Sulf1) is a transforming growth factor-β1 (TGF-β1)-responsive gene in normal human lung fibroblasts and functions as a negative feedback regulator of TGF-β1 and that TGF-β1 induces the expression of Sulf1 as well as that of th more

• HPAEC‐PAD method for the analysis of alkaline hydrolyzates of Haemophilus influenzae type b capsular polysaccharide

  ABSTRACT A gradient method has been devised for the rapid analysis of alkaline hydrolyzates of Haemophilus influenzae type b (Hib) capsular polysaccharide‐based vaccines by high‐performance anion exchange chromatography with pulsed amperometric detection (HPAEC‐PAD). As compared with published p more

• Transgenic resistance to Bamboo mosaic virus by expression of interfering satellite RNA

  Summary Plant genetic engineering has broadened the options for plant virus resistance and is mostly based on pathogen‐derived resistance. Previously, we have shown that interfering satellite RNA (satRNA) of Bamboo mosaic virus (satBaMV) greatly reduces Bamboo mosaic virus (BaMV) accumulation an more

Market studies Interference

• Sports Medicine Implants Market - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

  Introduction GlobalData’s new report, “Sports Medicine Implants Market - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018” provides key data, information and analysis on the global sports medicine implants market. The report provides market landscape, competitive landsc more

• Algeria Pharmaceuticals and Healthcare Report Q2 2012

  BMI View: Algeria is a high-risk market for multinational drugmakers because of the combination of regional uncertainty and state interference in its business environment. The country’s protectionist import policies, together with its failure to anticipate consumer demands, would have damaged total more

Websites Interference